The activation of PPARα plays a central role in regulating lipid metabolism and reducing triglyceride accumulation in the liver, thus contributing to the prevention of hepatic steatosis and conditions such as MASLD and hyperlipidemia [97]. The gene discussed is PPARA; the disease is Hepatic steatosis.